2 recruiting, 1 completed. 3 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 3 | Recruiting 2, Completed 1 |
Follow PCV 20: new trials by email Literature Review of PCV 20 trials Research Report on PCV 20
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Dose-Ranging Study to Evaluate a 25-Valent Pneumococcal Conjugate Vaccine IVT PCV-25 Formulation A, IVT PCV-25 Formulation B, IVT PCV-25 Formulation C - Pneumococcal Vaccines | Phase 2 | Completed | Inventprise Inc. | 220 | 2023-10-25 | 2026-03-17 |
| Anti-pneumococcal Vaccine Strategy in Patients With Chronic Lymphocytic Leukemia Pneumococcal 20-valent Conjugate Vaccine, Pneumococcal Polyvalent Vaccine - Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma | Phase 2 | Recruiting | Seema Bhat | 80 | 2023-09-29 | 2026-01-07 |
| Pneumococcal Pneumonia Vaccine Series (PCV20 and PPSV23) in Patients With Chronic Lymphocytic Leukemia Associated Immunodeficiency, PROTECT CLL Trial Pneumococcal 20-valent Conjugate Vaccine, Pneumococcal Polyvalent Vaccine - Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma | Phase 2 | Recruiting | University of Utah | 61 | 2022-01-31 | 2026-04-09 |
Leukemia, Lymphocytic, Chronic, B-Cell (2)
Inventprise Inc. (1) · Seema Bhat (1) · University of Utah (1)
United States (2) · Canada (1)
Daniel Ermann, MD (1) · Seema A Bhat, MD (1) · Sybil Tasker, MD, MPH, FIDSA (1)